IL6 and gastric cancer: It has been shown that TAMs-released TNF and IL-6 influence the expression of programmed-death ligand 1 (PD-L1) in gastric tumor cells via NF-κB and STAT3 signaling, thereby promoting the proliferation of GC cells [127].